AI assistant
Vaxcyte, Inc. — Director's Dealing 2020
Dec 23, 2020
31100_dirs_2020-12-22_db565403-34e3-487b-a79c-2301cca9edfc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2020-12-21
Reporting Person: PICKERING GRANT (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-21 | Common Stock | M | 15000 | $1.79 | Acquired | 588191 | Direct |
| 2020-12-21 | Common Stock | S | 7196 | $28.42 | Disposed | 580995 | Direct |
| 2020-12-21 | Common Stock | S | 5691 | $29.08 | Disposed | 575304 | Direct |
| 2020-12-21 | Common Stock | S | 2113 | $29.88 | Disposed | 573191 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-12-21 | Stock Option (right to buy) | $1.79 | M | 15000 | Disposed | 2027-05-17 | Common Stock (15000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 355660 | Indirect |
Footnotes
F1: Includes 1,562 shares acquired under the Employment Stock Purchase Plan on November 17, 2020.
F2: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F3: The price reported is a weighted-average price. The shares were sold at prices ranging from $27.73 to $28.70. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4: The price reported is a weighted-average price. The shares were sold at prices ranging from $28.73 to $29.64. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5: The price reported is a weighted-average price. The shares were sold at prices ranging from $29.73 to $30.165. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F6: 1/4 of the shares subject to the option vested on March 4, 2018, and 1/48 of the shares vest monthly thereafter.